Alp Kazancioglu

Alp Kazancioglu

Auto-generated profile, based on publicly available information

Alp Kazancioglu

Department of Pediatric Allergy, Faculty of Medicine Hacettepe University Ankara Turkey

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2025 in Allergy
Verified
Journal Article
Open access
AKAlp Kazancioglu
Alp Kazancioglu
HHHuey‐Jy Huang
Huey‐Jy Huang
SASengul Aksakal
Sengul Aksakal
IBIsmet Bulut
Ismet Bulut
MBMaria-Roxana Buzan
Maria-Roxana Buzan
RVRudolf Valenta
Rudolf Valenta
Background: Molecular immunoglobulin E ( IgE ) reactivity profiling with multiple micro‐arrayed allergens is a valuable tool in allergy diagnosis and has provided fundamental insights into the evolution of allergic sensitization in longitudinal birth cohort studies. However, there is a need for systematic cross‐sectional population‐based studies. Methods: A prospective, systematic and cross‐sectional population study was performed involving 1000 adult subjects from five centers (İstanbul, Ankara, İzmir, Kayseri, Samsun) representing different climatic areas of Türkiye (Turkey). In each center adult subjects with ( n = 100) and without ( n = 100) allergic symptoms who were born and grew up in the region were recruited. Subjects underwent skin prick testing with a panel of common aeroallergen extracts and were tested for IgE reactivity to 108 micro‐arrayed allergen molecules. Results: IgE reactivity profiles of respiratory allergens differed in the five centers according to the regional allergen exposome and climate. Interestingly, Kayseri with a high‐altitude, continental climate was identified as hypoallergenic region with low frequency of allergic symptoms and strongly reduced molecular sensitization rates. Between 31%–55% of subjects without allergic symptoms showed IgE sensitization to at least one of the allergens tested but allergen‐specific IgE levels, numbers of recognized allergens and rates of poly‐sensitization were more frequent in symptomatic individuals. Conclusions: This is the first comprehensive, systematic, prospective and cross‐sectional study investigating molecular IgE sensitization profiles in a region at the crossroads of Europe, Asia, and Africa with different climatic conditions. It reveals clinically relevant differences in regional molecular IgE sensitization profiles depending on the allergen exposome and identifies a hypoallergenic region with distinct climatic features.

4 January 2025 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
AKAlp Kazancioglu
Alp Kazancioglu
MOMelike Ocak
Melike Ocak
ÜŞümit şahiner
ümit şahiner
OSOzge Soyer
Ozge Soyer
BSBulent Sekerel
Bulent Sekerel
Background: Sesame allergy (SA) is a growing concern because of its association with severe reactions and the limited knowledge of long‐term outcomes. Objective: This retrospective study aimed to identify the risk factors influencing persistent SA (PSA) in children to improve management and select suitable candidates for oral immunotherapy (OIT). Methods: We analyzed the electronic medical records of 84 children with confirmed SA, as defined by consistent clinical reactions and immunoglobulin E (IgE)‐mediated sensitization. Patients were followed for a median (IQR) of 56.5 (46.0–82.5) months. Results: Most participants were male (72.6%) with concurrent food allergies (71.4%). They experienced a median (IQR) of 3.0 (2.0–3.7) allergic episodes, with 46.4% experiencing at least one anaphylactic reaction. PSA was observed in 82.1% (69/84) of the patients. A larger skin prick test (SPT) wheal size at the first reaction (adjusted OR = 1.79, CI:1.05–3.04; p = .03) and allergic reaction grade≥2 (adjusted OR = 19.93, CI:1.37–289.13; p = .02) were independent risk factors for persistence. A 3‐fold increase in the likelihood of persistence was observed in patients with SPT results greater than 6.7 mm at first reaction compared with those with results less than 6.7 mm during follow‐up (HR = 3.08; CI:1.17–8.12; p = .02). Patients with sustained or increased SPT wheal size (93% remained allergic) and specific IgE (95% remained allergic) at the final visit were more likely to have PSA, whereas those with decreased levels (37% and 39% developed natural tolerance, respectively) were less likely to have resolved SA. Conclusions: This study identified novel risk factors for PSA, including SPT wheal size at the first reaction, reaction severity, and sustained sensitization markers. These findings can inform management strategies and the selection of OIT candidates. Further long‐term studies are crucial to elucidate the natural history of SA across populations and to evaluate early interventions, such as OIT.

21 July 2025 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
AKAlp Kazancioglu
Alp Kazancioglu
COCansu Ozdemiral
Cansu Ozdemiral
PCPinar Gur Cetinkaya
Pinar Gur Cetinkaya
MOMelike Ocak
Melike Ocak
USUmit Murat Sahiner
Umit Murat Sahiner
OSOzge Soyer
Ozge Soyer

19 August 2025 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
AKAlp Kazancioglu
Alp Kazancioglu
ÜŞümit şahiner
ümit şahiner
MEMeltem Akgul Erdal
Meltem Akgul Erdal
EYEbru Yalcin
Ebru Yalcin
NENagehan Emiralioglu
Nagehan Emiralioglu
OSOzge Soyer
Ozge Soyer

23 June 2026 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
AKAlp Kazancioglu
Alp Kazancioglu
SDSevda Tuten Dal
Sevda Tuten Dal
IKIlteber Konuralp
Ilteber Konuralp
OSOzge Soyer
Ozge Soyer
BSBulent Sekerel
Bulent Sekerel

13 August 2026 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
FCFigen Celebi Celik
Figen Celebi Celik
AKAlp Kazancioğlu
Alp Kazancioğlu
SGSoner Günder
Soner Günder
MOMeli̇kE Ocak
Meli̇kE Ocak
BUBerna Uzunoğlu
Berna Uzunoğlu
ÜŞÜmi̇t Murat Şahi̇nEr
Ümi̇t Murat Şahi̇nEr
Background/aim: This study aimed to evaluate the frequency, timing, severity, and clinical predictors of systemic reactions in children receiving subcutaneous allergen-specific immunotherapy (SCIT) with house dust mite (HDM) and grass pollen extracts under real-world clinical conditions. Materials and methods: This multicenter retrospective study included 623 children with moderate-to-severe allergic rhinitis, with or without asthma, who received SCIT between 2006 and 2023 at two tertiary pediatric allergy centers. Clinical characteristics, laboratory findings, immunotherapy protocols, and systemic reactions (SRs) were recorded and graded according to the updated 2024 World Allergy Organization (WAO) systemic reaction scale. Results: SCIT was well tolerated. Systemic reactions occurred in 10.7%, corresponding to 0.27% per injection. Most SRs were mild-to-moderate (WAO grades 1–2), and approximately three-quarters occurred during the maintenance phase. A progressive decline in SR incidence was observed throughout the treatment period. In the pollen SCIT subgroup, asthma was the only independent predictor of SRs (OR, 2.35; 95% CI 1.13–4.88; p = 0.022). No life-threatening reactions or fatalities were observed. Conclusion: Pediatric SCIT with pollen and HDM extracts demonstrated a favorable safety profile, with infrequent and predominantly nonsevere systemic reactions. The association between asthma and SRs in pollen SCIT highlights the importance of optimal asthma control throughout immunotherapy.